Nihal Ahmad

Affiliations: 
University of Wisconsin, Madison, Madison, WI 
Area:
Oncology, Cell Biology
Google:
"Nihal Ahmad"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Singh CK, Fernandez S, Chhabra G, et al. (2024) The role of Collagen Triple Helix Repeat Containing 1 (CTHRC1) in cancer development and progression. Expert Opinion On Therapeutic Targets
Chhabra G, Singh CK, Ndiaye MA, et al. (2024) Role of PLK1/NUMB/NOTCH in epithelial-mesenchymal transition in human melanoma. Npj Precision Oncology. 8: 6
Su S, Ndiaye MA, Guzmán-Pérez G, et al. (2023) Potential Tumor Suppressor Role of Polo-like Kinase 5 in Cancer. Cancers. 15
Dong B, Simonson L, Vold S, et al. (2022) Frizzled 6 promotes melanoma cell invasion but not proliferation by regulating canonical Wnt signaling and EMT. The Journal of Investigative Dermatology
Singh CK, Denu RA, Nihal M, et al. (2022) PLK4 is upregulated in prostate cancer and its inhibition reduces centrosome amplification and causes senescence. The Prostate
Su S, Chhabra G, Singh CK, et al. (2021) PLK1 inhibition-based combination therapies for cancer management. Translational Oncology. 16: 101332
Singh CK, George J, Chhabra G, et al. (2021) Genetic Manipulation of Sirtuin 3 Causes Alterations of Key Metabolic Regulators in Melanoma. Frontiers in Oncology. 11: 676077
Chhabra G, Singh CK, Amiri D, et al. (2021) Recent Advancements on Immunomodulatory Mechanisms of Resveratrol in Tumor Microenvironment. Molecules (Basel, Switzerland). 26
Garvey DR, Chhabra G, Ndiaye MA, et al. (2021) Role of polo-like kinase 4 (PLK4) in epithelial cancers and recent progress in its small molecule targeting for cancer management. Molecular Cancer Therapeutics
Su S, Chhabra G, Ndiaye MA, et al. (2020) PLK1 and NOTCH Positively Correlate in Melanoma and their Combined Inhibition Results in Synergistic Modulations of Key Melanoma Pathways. Molecular Cancer Therapeutics
See more...